Jazz Raising Hematology/Oncology Reach Further With ImmunoGen Deal

 
• By Sten Stovall

Ireland-based Jazz Pharma is extending its shift away from specialty pharma with an option-based deal with ImmunoGen involving three antibody-drug conjugate programs.

Project building
Jazz Pharma Does Deal With ImmunoGen On Three ADC Programs • Source: Shutterstock

More from Strategy

More from Business